Search

Hien Thi Tran

Examiner (ID: 9609)

Most Active Art Unit
1764
Art Unit(s)
1764, 1312, 1801
Total Applications
1244
Issued Applications
852
Pending Applications
137
Abandoned Applications
255

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6689046 [patent_doc_number] => 20030032771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Peptide inhibitors of cellular proliferation' [patent_app_type] => new [patent_app_number] => 09/782816 [patent_app_country] => US [patent_app_date] => 2001-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10620 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032771.pdf [firstpage_image] =>[orig_patent_app_number] => 09782816 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/782816
Peptide inhibitors of cellular proliferation Feb 13, 2001 Abandoned
Array ( [id] => 6720729 [patent_doc_number] => 20030054417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Epithelial protein lost in neoplasm (EPLIN)' [patent_app_type] => new [patent_app_number] => 09/783732 [patent_app_country] => US [patent_app_date] => 2001-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 31780 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20030054417.pdf [firstpage_image] =>[orig_patent_app_number] => 09783732 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/783732
Epithelial protein lost in neoplasm (EPLIN) Feb 12, 2001 Abandoned
Array ( [id] => 6744596 [patent_doc_number] => 20030021779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers' [patent_app_type] => new [patent_app_number] => 09/782397 [patent_app_country] => US [patent_app_date] => 2001-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 27738 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20030021779.pdf [firstpage_image] =>[orig_patent_app_number] => 09782397 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/782397
Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers Feb 12, 2001 Abandoned
Array ( [id] => 6356770 [patent_doc_number] => 20020058041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Kidney-specific tumor vaccine directed against kidney tumor antigen G-250' [patent_app_type] => new [patent_app_number] => 09/783708 [patent_app_country] => US [patent_app_date] => 2001-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 22577 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058041.pdf [firstpage_image] =>[orig_patent_app_number] => 09783708 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/783708
Kidney-specific tumor vaccine directed against kidney tumor antigen G-250 Feb 12, 2001 Issued
Array ( [id] => 6519333 [patent_doc_number] => 20020192223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Novel antibody conjugates reactive with human carcinomas' [patent_app_type] => new [patent_app_number] => 09/782504 [patent_app_country] => US [patent_app_date] => 2001-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 74 [patent_figures_cnt] => 74 [patent_no_of_words] => 52363 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192223.pdf [firstpage_image] =>[orig_patent_app_number] => 09782504 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/782504
Novel antibody conjugates reactive with human carcinomas Feb 11, 2001 Abandoned
Array ( [id] => 668644 [patent_doc_number] => 07094886 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-22 [patent_title] => 'Evi27 gene sequences and protein encoded thereby' [patent_app_type] => utility [patent_app_number] => 09/778971 [patent_app_country] => US [patent_app_date] => 2001-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 22 [patent_no_of_words] => 13118 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094886.pdf [firstpage_image] =>[orig_patent_app_number] => 09778971 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/778971
Evi27 gene sequences and protein encoded thereby Feb 1, 2001 Issued
Array ( [id] => 7432771 [patent_doc_number] => 20040002124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Cyr61 compositions and methods' [patent_app_type] => new [patent_app_number] => 10/182432 [patent_app_country] => US [patent_app_date] => 2002-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 49728 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002124.pdf [firstpage_image] =>[orig_patent_app_number] => 10182432 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/182432
CYR61 compositions and methods Jan 30, 2001 Issued
Array ( [id] => 6876478 [patent_doc_number] => 20010006631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-05 [patent_title] => 'Treating tumors using implants comprising combinations of allogeneic cells' [patent_app_type] => new-utility [patent_app_number] => 09/771263 [patent_app_country] => US [patent_app_date] => 2001-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21384 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20010006631.pdf [firstpage_image] =>[orig_patent_app_number] => 09771263 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/771263
Treating tumors using implants comprising combinations of allogeneic cells Jan 25, 2001 Issued
Array ( [id] => 7027813 [patent_doc_number] => 20010014328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-16 [patent_title] => 'Therapeutic multispecific compounds comprised of anti-Fcalpha receptor antibodies' [patent_app_type] => new [patent_app_number] => 09/772120 [patent_app_country] => US [patent_app_date] => 2001-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 24179 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20010014328.pdf [firstpage_image] =>[orig_patent_app_number] => 09772120 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/772120
Therapeutic multispecific compounds comprised of anti-Fcalpha receptor antibodies Jan 25, 2001 Abandoned
09/831744 Phospholipase inhibitors for the treatment of cancer Jan 24, 2001 Abandoned
Array ( [id] => 6769517 [patent_doc_number] => 20030215457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Compositions and methods for treatment of cancer' [patent_app_type] => new [patent_app_number] => 10/182033 [patent_app_country] => US [patent_app_date] => 2002-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 44839 [patent_no_of_claims] => 100 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215457.pdf [firstpage_image] =>[orig_patent_app_number] => 10182033 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/182033
Compositions and methods for treatment of cancer Jan 24, 2001 Issued
Array ( [id] => 247194 [patent_doc_number] => 07585946 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-08 [patent_title] => 'Active lymphotoxin-β receptor immunoglobulin chimeric protein compositions' [patent_app_type] => utility [patent_app_number] => 09/767370 [patent_app_country] => US [patent_app_date] => 2001-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 21 [patent_no_of_words] => 10027 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/585/07585946.pdf [firstpage_image] =>[orig_patent_app_number] => 09767370 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/767370
Active lymphotoxin-β receptor immunoglobulin chimeric protein compositions Jan 22, 2001 Issued
Array ( [id] => 6696361 [patent_doc_number] => 20030108555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Methods and compositions for cancer treatment' [patent_app_type] => new [patent_app_number] => 09/764224 [patent_app_country] => US [patent_app_date] => 2001-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6309 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20030108555.pdf [firstpage_image] =>[orig_patent_app_number] => 09764224 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/764224
Composition for targeted cell treatment Jan 15, 2001 Issued
Array ( [id] => 1088872 [patent_doc_number] => 06828111 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-07 [patent_title] => 'Three-dimensional in vitro model of human preneoplastic breast disease' [patent_app_type] => B2 [patent_app_number] => 09/759365 [patent_app_country] => US [patent_app_date] => 2001-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 69 [patent_no_of_words] => 20064 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/828/06828111.pdf [firstpage_image] =>[orig_patent_app_number] => 09759365 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/759365
Three-dimensional in vitro model of human preneoplastic breast disease Jan 15, 2001 Issued
Array ( [id] => 5905653 [patent_doc_number] => 20020142299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'PTD-modified proteins' [patent_app_type] => new [patent_app_number] => 09/757824 [patent_app_country] => US [patent_app_date] => 2001-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11867 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142299.pdf [firstpage_image] =>[orig_patent_app_number] => 09757824 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/757824
PTD-modified proteins Jan 8, 2001 Abandoned
09/601897 NT-3 and medulloblastoma Jan 4, 2001 Abandoned
Array ( [id] => 7226660 [patent_doc_number] => 20040072993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Alpha (2) macroglobulin receptor as a heat shock protein receptor and uses thereof' [patent_app_type] => new [patent_app_number] => 09/750972 [patent_app_country] => US [patent_app_date] => 2000-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 91 [patent_figures_cnt] => 91 [patent_no_of_words] => 40980 [patent_no_of_claims] => 96 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 09750972 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/750972
α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof Dec 27, 2000 Issued
Array ( [id] => 6541404 [patent_doc_number] => 20020110538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'Methods and products for tumor immunotherapy using cytokines' [patent_app_type] => new [patent_app_number] => 09/749649 [patent_app_country] => US [patent_app_date] => 2000-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16527 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20020110538.pdf [firstpage_image] =>[orig_patent_app_number] => 09749649 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/749649
Methods and products for tumor immunotherapy using cytokines Dec 26, 2000 Abandoned
Array ( [id] => 6757710 [patent_doc_number] => 20030005487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Isolation and characterization of heat shock protein' [patent_app_type] => new [patent_app_number] => 09/742160 [patent_app_country] => US [patent_app_date] => 2000-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 13295 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20030005487.pdf [firstpage_image] =>[orig_patent_app_number] => 09742160 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/742160
Isolation and characterization of heat shock protein Dec 19, 2000 Abandoned
Array ( [id] => 6095230 [patent_doc_number] => 20020051765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Method of cancer treatment' [patent_app_type] => new [patent_app_number] => 09/741503 [patent_app_country] => US [patent_app_date] => 2000-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11057 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20020051765.pdf [firstpage_image] =>[orig_patent_app_number] => 09741503 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/741503
Method of cancer treatment Dec 18, 2000 Abandoned
Menu